Schneider, Stefan
Blick, Gary
Burke, Christina
Ward, Douglas
Benson, Paul
Felizarta, Franco
Green, Dallas
Donovan, Cynthia
Harper, Gavin
Merrill, Deanna
Metzner, Aimee A.
Mycock, Katie
Wallis, Hannah
Patarroyo, Jimena
Brogan, Andrew P.
Oglesby, Alan http://orcid.org/0000-0002-8121-4478
Article History
Received: 18 December 2023
Accepted: 12 March 2024
First Online: 3 April 2024
Declarations
:
: Stefan Schneider has received honoraria from GSK. Gary Blick has received honoraria from ViiV Healthcare for participation in speakers bureaus and advisory boards. Christina Burke has received study support from Adelphi Real World and ViiV Healthcare, paid to her institution. Douglas Ward has no conflicts to report. Paul Benson has received honoraria from ViiV Healthcare. Franco Felizarta has received grants and honoraria from AbbVie, Gilead, and ViiV Healthcare. Dallas Green has served as a principal investigator or sub-investigator in clinical research trials sponsored by GSK and ViiV Healthcare and participated in speakers bureaus and advisory boards for GSK and ViiV Healthcare, and is a voting member of the Miami-Dade HIV/AIDS Partnership medical sub-committee. Cynthia Donovan, Deanna Merrill, Aimee A. Metzner, Jimena Patarroyo, Andrew P. Brogan, and Alan Oglesby are employees of ViiV Healthcare and may own stock in GSK. Gavin Harper, Katie Mycock, and Hannah Wallis are employees of Adelphi Real World, which was contracted by ViiV Healthcare for this study.
: Independent central institutional review board (IRB) ethical approval was granted by the Western IRB-Copernicus Group (WCG™ IRB, Princeton, NJ) on February 19, 2021 (reference number, 20210451). Subsequent ethics reviews were provided by WCG IRB for each site before initiation of data collection.